Document Detail


Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer.
MedLine Citation:
PMID:  18425518     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The purpose is to evaluate the accuracy of integrated FDG-PET/CT, compared with PET alone, for diagnosis of suspected recurrence of uterine cervical cancer. Fifty-two women who had undergone treatment for histopathologically proven cervical cancer received PET/CT with suspected recurrence. PET-alone and integrated PET/CT images were evaluated by two different experienced radiologists by consensus for each investigation. A final diagnosis was confirmed by histopathology, radiological imaging, and clinical follow-up for over 1 year. Patient-based analysis showed that the sensitivity, specificity, and accuracy of PET/CT were 92.0% (23/25), 92.6% (25/27), and 92.3% (48/52), respectively, while for PET, the corresponding figures were 80.0% (20/25), 77.8% (21/27), and 78.8% (41/52), respectively. PET/CT resolved the false-positive PET results due to hypermetabolic activity of benign/inflammatory lesions and physiological variants, and was able to detect lung metastasis, local recurrence, peritoneal dissemination, para-aortic lymph node metastasis, and pelvic lymph node metastasis missed by PET alone. However, tiny local recurrence and lymph node metastasis could not be detected even by PET/CT. FDG-PET/CT is a useful complementary modality for providing good anatomic and functional localization of sites of recurrence during follow-up of patients with cervical cancer.
Authors:
Kazuhiro Kitajima; Koji Murakami; Erena Yamasaki; Yasushi Domeki; Yasushi Kaji; Kazuro Sugimura
Related Documents :
2590038 - Modern diagnostic strategy for acoustic neuromas.
14736838 - Pet/ct in oncology: integration into clinical management of lymphoma, melanoma, and gas...
19544378 - Revisiting the role of positron-emission tomography/computed tomography in determining ...
14499138 - Conventional imaging and 2-deoxy-2-[18f]fluoro-d-glucose positron emission tomography f...
19468658 - Severe adverse drug reaction to gadobenate dimeglumine.
9377498 - Diagnosis of pulmonary metastases with turbo-se mr imaging.
Publication Detail:
Type:  Journal Article     Date:  2008-04-19
Journal Detail:
Title:  European radiology     Volume:  18     ISSN:  0938-7994     ISO Abbreviation:  Eur Radiol     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2008-09-11     Completed Date:  2009-01-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9114774     Medline TA:  Eur Radiol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  2040-7     Citation Subset:  IM    
Affiliation:
Department of Radiology, Dokkyo University School of Medicine, 880 Kita-kobayashi, Mibu, Shimotuka-gun, Tochigi, 321-0293, Japan. kitajima@med.kobe-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Female
Fluorodeoxyglucose F18 / diagnostic use*
Humans
Image Enhancement / methods*
Male
Middle Aged
Neoplasm Recurrence, Local / diagnosis*
Radiopharmaceuticals / diagnostic use
Reproducibility of Results
Sensitivity and Specificity
Tomography, X-Ray Computed / methods*
Uterine Cervical Neoplasms / diagnosis*
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Regulation of expression of rice thaumatin-like protein: inducibility by elicitor requires promoter ...
Next Document:  MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients.